Learn About CAPOS Syndrome

What is the definition of CAPOS Syndrome?
Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome is a neurological disorder. The syndrome gets its name from the different parts of the body it usually affects: Cerebellar ataxia: inflammation of the cerebellum, the part of the brain that helps control the coordination of muscle movement Areflexia: loss of reflexes Pes cavus: high arch in foot Optic atrophy: damage to the optic nerve of the eye Sensorinural hearing loss: damage to the nerves involved in hearing CAPOS syndrome typically begins after a fever-related illness with a sudden episode of ataxia, such as having a hard time walking or coordinating leg or arm movements. The ataxia is usually associated with generalized weakness and/or inflammation of the brain (encephalopathy). Pregnancy and delivery may also trigger episodes. Most people with CAPOS syndrome have one to three episodes during their lifetime. Other signs and symptoms during an episode may include low muscle tone, unusual eye movements (nystagmus or strabismus), problems with speech (dysarthria), difficulty swallowing (dysphagia), reduced or absent reflexes, and hearing loss. Some people may lose consciousness or go into a coma during an episode. Though many of the signs and symptoms of CAPOS syndrome get better as the fever and illness improve, some symptoms, including movement problems, may continue.
What are the alternative names for CAPOS Syndrome?
  • Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss
  • Autosomal dominant optic atrophy plus syndrome
  • CAPOS
  • CAPOS syndrome
  • Cerebellar ataxia - areflexia - pes cavus - optic atrophy - sensorineural hearing loss
  • Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
  • DOMINANT OPTIC ATROPHY PLUS SYNDROME
  • Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy
  • OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY
  • Optic atrophy - deafness- polyneuropathy - myopathy
  • Optic atrophy-deafness-polyneuropathy-myopathy syndrome
  • Treft-Sanborn-Carey syndrome
Who are the top CAPOS Syndrome Local Doctors?
Distinguished in CAPOS Syndrome
Distinguished in CAPOS Syndrome

Tele-Radiology Solutions

22 Llanfair Road, Unit 6, 
Ardmore, PA 
Languages Spoken:
English
Offers Telehealth

. Dr. Medarametla is rated as a Distinguished provider by MediFind in the treatment of CAPOS Syndrome. His top areas of expertise are CAPOS Syndrome, Pleurisy, Pleural Effusion, Vertebroplasty, and Bone Graft.

Distinguished in CAPOS Syndrome
Distinguished in CAPOS Syndrome

Reading Hospital

420 South 5th Avenue, 
West Reading, PA 
Languages Spoken:
English

. Dr. Yamamoto is rated as a Distinguished provider by MediFind in the treatment of CAPOS Syndrome. His top areas of expertise are Stroke, CAPOS Syndrome, Aseptic and Alopecic Nodules of Scalp (AANS), Osteotomy, and Carotid Artery Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Glen H. Hatcher
Advanced in CAPOS Syndrome
Advanced in CAPOS Syndrome

Blue Ridge Radiology, P.C.

3053 W State St, 
Bristol, TN 
Languages Spoken:
English
Offers Telehealth

. Dr. Hatcher is rated as an Advanced provider by MediFind in the treatment of CAPOS Syndrome. His top areas of expertise are CAPOS Syndrome, Pleurisy, Pleural Effusion, and Visceromegaly.

What are the latest CAPOS Syndrome Clinical Trials?
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center